Cargando…

Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients

We investigated whether HLA class II eplet mismatch was related to dnDSA development and analyzed its combined impact with tacrolimus levels for kidney transplantation outcomes. A total of 347 kidney transplants were included. HLA Matchmaker was used for the single molecular eplet, total eplet, anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyeyoung, Min, Ji Won, Kang, Hyunhye, Lee, Hanbi, Eum, Sang Hun, Park, Yohan, Yang, Chul Woo, Chung, Byung Ha, Oh, Eun-Jee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267119/ https://www.ncbi.nlm.nih.gov/pubmed/35806362 http://dx.doi.org/10.3390/ijms23137357

Ejemplares similares

Donor-Derived Cell-Free DNA at 1 Month after Kidney Transplantation Relates to HLA Class II Eplet Mismatch Load
por: González-López, Elena, et al.
Publicado: (2023)

Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients
por: Lee, Haeun, et al.
Publicado: (2023)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

HLA Eplet Mismatches in Kidney Transplantation: More Than Just Adding Things Up
por: Sypek, Matthew P., et al.
Publicado: (2021)

Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation
por: Park, Yohan, et al.
Publicado: (2021)

Determining Clinical Thresholds for Donor HLA Eplet Compatibility to Predict Best Outcomes Following Lung Transplantation
por: Hiho, Steven J., et al.
Publicado: (2022)

On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss
por: Mohammadhassanzadeh, Hossein, et al.
Publicado: (2021)

HLA-Epitope Matching or Eplet Risk Stratification: The Devil Is in the Details
por: Tambur, Anat R.
Publicado: (2018)

Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2018)

The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation
por: Larkins, Nicholas G., et al.
Publicado: (2022)

Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study
por: Schawalder, Lara, et al.
Publicado: (2020)

Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome
por: Meneghini, Maria, et al.
Publicado: (2018)

High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia
por: Stefańska, Katarzyna, et al.
Publicado: (2023)

DQA1 Eplet Mismatch Load As an Independent Risk Factor of CLAD After Lung Transplantation
por: González-López, Elena, et al.
Publicado: (2023)

A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry
por: Bezstarosti, Suzanne, et al.
Publicado: (2022)

Combined impact of the inter and intra-patient variability of tacrolimus blood level on allograft outcomes in kidney transplantation
por: Park, Yohan, et al.
Publicado: (2022)

Donor–Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms
por: Jethwani, Priyanka, et al.
Publicado: (2022)

Can We Use Eplets (or Molecular) Mismatch Load Analysis to Improve Organ Allocation? The Hope and the Hype
por: Tambur, Anat R., et al.
Publicado: (2022)

Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
por: Baghai Arassi, Maral, et al.
Publicado: (2022)

Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort
por: Davis, Scott, et al.
Publicado: (2020)

Donor-specific antibodies, glomerulitis, and human leukocyte antigen B eplet mismatch are risk factors for peritubular capillary C4d deposition in renal allografts
por: Zheng, Jin, et al.
Publicado: (2021)

Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
por: Meneghini, Maria, et al.
Publicado: (2021)

Alterations in the Mineral Bone Metabolism of Living Kidney Donors After Uni-Nephrectomy: Prospective Observational Study
por: Lee, Hanbi, et al.
Publicado: (2021)

The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA
por: Jucaud, Vadim
Publicado: (2017)

Comparison of CT volumetry versus nuclear renography for predicting remaining kidney function after uninephrectomy in living kidney donors
por: Eum, Sang Hun, et al.
Publicado: (2022)

Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum
por: Won, Dong Il, et al.
Publicado: (2020)

Eplet-Predicted Antigens: An Attempt to Introduce Eplets into Unacceptable Antigen Determination and Calculated Panel-Reactive Antibody Calculation Facilitating Kidney Allocation
por: Wu, Wenrui, et al.
Publicado: (2022)

Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate‐ or prolonged‐release tacrolimus
por: Vondrak, Karel, et al.
Publicado: (2019)

Donor-Recipient Size Mismatch in Paediatric Renal Transplantation
por: Donati-Bourne, J., et al.
Publicado: (2014)

Donor and Recipient Age-Mismatches: The Potential of Transferring Senescence
por: Iske, Jasper, et al.
Publicado: (2021)

Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis
por: Philogene, Mary Carmelle, et al.
Publicado: (2019)

The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
por: Kim, Sang Jin, et al.
Publicado: (2022)

Correlation and agreement between eplet mismatches calculated using serological, low-intermediate and high resolution molecular human leukocyte antigen typing methods
por: Fidler, Samantha, et al.
Publicado: (2018)

Correction to: Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis
por: Philogene, Mary Carmelle, et al.
Publicado: (2019)

New Insights Into SARS-CoV-2-specific Antibody Levels in Kidney Transplantation Recipients After Three Vaccination Doses
por: Kang, Hyunhye, et al.
Publicado: (2024)

Clinical experience with once–daily tacrolimus in de novo kidney transplant recipients from living donors in Japan: 1–year follow up
por: Ishida, Kenichiro, et al.
Publicado: (2013)

Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2016)

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients
por: O'Leary, Jacqueline G., et al.
Publicado: (2016)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

Impact of high body mass index on allograft outcomes in kidney transplant recipients with presensitization to human leukocyte antigen
por: Park, Yohan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9l02qhrfu7egl71015eqike6p1